Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: Wall Street's top stories at midday » 12:06
04/13/21
04/13
12:06
04/13/21
12:06
JNJ

Johnson & Johnson

$157.65 /

-3.935 (-2.44%)

, MRNA

Moderna

$149.34 /

+10.05 (+7.22%)

, GRAB

Grab

/

+

, COIN

Coinbase

$0.00 /

+ (+0.00%)

, BA

Boeing

$251.46 /

+1.8 (+0.72%)

, AGC

Altimeter Growth

$13.46 /

-0.46 (-3.30%)

, NVCR

Novocure

$185.99 /

+54.38 (+41.32%)

, CDLX

Cardlytics

$102.70 /

-9.03 (-8.08%)

, AHCO

AdaptHealth

$31.35 /

-5.7 (-15.38%)

, BALY

Bally's

$54.81 /

-5.99 (-9.85%)

, JKPTF

Gamesys Group

$27.00 /

+ (+0.00%)

The major averages are…

ShowHide Related Items >><<
NVCR Novocure
$185.99 /

+54.38 (+41.32%)

MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

CDLX Cardlytics
$102.70 /

-9.03 (-8.08%)

BALY Bally's
$54.81 /

-5.99 (-9.85%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AHCO AdaptHealth
$31.35 /

-5.7 (-15.38%)

AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

09:34 Today Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
09:33 Today Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
09:21 Today JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
08:15 Today Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
MRNA Moderna
$149.34 /

+10.05 (+7.22%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
GRAB Grab
/

+

COIN Coinbase
$0.00 /

+ (+0.00%)

09:55 Today
Fly Intel: Top five analyst initiations
06:35 Today MoffettNathanson
Coinbase initiated with a Buy at MoffettNathanson
04/07/21 JMP Securities
Coinbase report shows 'substantial business momentum,' says JMP Securities
03/03/21
Fly Intel: Top five analyst initiations
BA Boeing
$251.46 /

+1.8 (+0.72%)

04/09/21 Baird
Baird says add to Boeing on any weakness due to 'tiny fix' needed for MAX jets
03/29/21 Goldman Sachs
Boeing resuming 787 deliveries removes overhang, says Goldman Sachs
03/19/21 Susquehanna
Boeing price target raised to $300 from $250 at Susquehanna
03/15/21 Morgan Stanley
Aerospace sector upgraded to Attractive from Cautious at Morgan Stanley
AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

NVCR Novocure
$185.99 /

+54.38 (+41.32%)

11:34 Today Wells Fargo
Novocure price target raised to $215 from $135 at Wells Fargo
10:48 Today Guggenheim
Zai Lab price target raised to $250 from $165 at Guggenheim
09:26 Today Piper Sandler
DMC review 'clear positive' for Novocure, says Piper Sandler
03/01/21 Mizuho
Novocure price target raised to $175 from $150 at Mizuho
CDLX Cardlytics
$102.70 /

-9.03 (-8.08%)

03/16/21 JPMorgan
Cardlytics price target raised to $130 from $110 at JPMorgan
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/02/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
AHCO AdaptHealth
$31.35 /

-5.7 (-15.38%)

11:03 Today Canaccord
Charges against McGee not related to AdaptHealth, says Canaccord
10:35 Today Stifel
Stifel says AdaptHealth co-CEO news shouldn't have immediate impact on outlook
04/12/21 Baird
AdaptHealth price target raised to $49 from $47 at Baird
03/18/21 Truist
AdaptHealth initiated with a Buy at Truist amid home health market shift
BALY Bally's
$54.81 /

-5.99 (-9.85%)

04/08/21 KeyBanc
Bally's price target raised to $70 from $65 at KeyBanc
03/29/21 Truist
Early March casino data looks 'very positive,' says Truist
03/25/21 Stifel
Bally's price target raised to $75 from $70 at Stifel
03/24/21 Jefferies
Gamesys Group and Bally's an 'interesting combination,' says Jefferies
JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

03/16/21 Jefferies
Gamesys Group price target raised to 2,150 GBp from 1,930 GBp at Jefferies
03/10/21 Berenberg
Gamesys Group price target raised to 1,700 GBp from 1,550 GBp at Berenberg
03/10/21 Deutsche Bank
Gamesys Group price target raised to 1,580 GBp from 1,510 GBp at Deutsche Bank
NVCR Novocure
$185.99 /

+54.38 (+41.32%)

MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

COIN Coinbase
$0.00 /

+ (+0.00%)

CDLX Cardlytics
$102.70 /

-9.03 (-8.08%)

BALY Bally's
$54.81 /

-5.99 (-9.85%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AHCO AdaptHealth
$31.35 /

-5.7 (-15.38%)

  • 14
    Apr
  • 16
    Apr
  • 03
    Mar
  • 06
    Jan
  • 15
    Dec
  • 03
    Sep
  • 01
    Jul
  • 19
    May
MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BALY Bally's
$54.81 /

-5.99 (-9.85%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BALY Bally's
$54.81 /

-5.99 (-9.85%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AHCO AdaptHealth
$31.35 /

-5.7 (-15.38%)

AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

On The Fly
Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine » 11:12
04/13/21
04/13
11:12
04/13/21
11:12
JNJ

Johnson & Johnson

$157.42 /

-4.165 (-2.58%)

, MRNA

Moderna

$150.11 /

+10.82 (+7.77%)

, PFE

Pfizer

$37.14 /

+0.16 (+0.43%)

Shares of Johnson &…

ShowHide Related Items >><<
PFE Pfizer
$37.14 /

+0.16 (+0.43%)

MRNA Moderna
$150.11 /

+10.82 (+7.77%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

09:34 Today Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
09:33 Today Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
09:21 Today JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
08:15 Today Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
MRNA Moderna
$150.11 /

+10.82 (+7.77%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
PFE Pfizer
$37.14 /

+0.16 (+0.43%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PFE Pfizer
$37.14 /

+0.16 (+0.43%)

MRNA Moderna
$150.11 /

+10.82 (+7.77%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

  • 19
    May
PFE Pfizer
$37.14 /

+0.16 (+0.43%)

MRNA Moderna
$150.11 /

+10.82 (+7.77%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

PFE Pfizer
$37.14 /

+0.16 (+0.43%)

MRNA Moderna
$150.11 /

+10.82 (+7.77%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

PFE Pfizer
$37.14 /

+0.16 (+0.43%)

MRNA Moderna
$150.11 /

+10.82 (+7.77%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

Options
Moderna call volume above normal and directionally bullish » 10:25
04/13/21
04/13
10:25
04/13/21
10:25
MRNA

Moderna

$149.00 /

+9.71 (+6.97%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$149.00 /

+9.71 (+6.97%)

MRNA Moderna
$149.00 /

+9.71 (+6.97%)

09:33 Today Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
08:15 Today Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
MRNA Moderna
$149.00 /

+9.71 (+6.97%)

  • 19
    May
MRNA Moderna
$149.00 /

+9.71 (+6.97%)

MRNA Moderna
$149.00 /

+9.71 (+6.97%)

MRNA Moderna
$149.00 /

+9.71 (+6.97%)

Hot Stocks
White House says J&J pause will not significantly impact vaccination plan » 09:47
04/13/21
04/13
09:47
04/13/21
09:47
JNJ

Johnson & Johnson

$157.25 /

-4.335 (-2.68%)

, MRNA

Moderna

$147.74 /

+8.45 (+6.07%)

, PFE

Pfizer

$37.35 /

+0.37 (+1.00%)

The White House said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$37.35 /

+0.37 (+1.00%)

MRNA Moderna
$147.74 /

+8.45 (+6.07%)

JNJ Johnson & Johnson
$157.25 /

-4.335 (-2.68%)

JNJ Johnson & Johnson
$157.25 /

-4.335 (-2.68%)

09:34 Today Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
09:33 Today Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
09:21 Today JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
08:15 Today Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
MRNA Moderna
$147.74 /

+8.45 (+6.07%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
PFE Pfizer
$37.35 /

+0.37 (+1.00%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PFE Pfizer
$37.35 /

+0.37 (+1.00%)

MRNA Moderna
$147.74 /

+8.45 (+6.07%)

JNJ Johnson & Johnson
$157.25 /

-4.335 (-2.68%)

  • 19
    May
PFE Pfizer
$37.35 /

+0.37 (+1.00%)

MRNA Moderna
$147.74 /

+8.45 (+6.07%)

JNJ Johnson & Johnson
$157.25 /

-4.335 (-2.68%)

PFE Pfizer
$37.35 /

+0.37 (+1.00%)

MRNA Moderna
$147.74 /

+8.45 (+6.07%)

JNJ Johnson & Johnson
$157.25 /

-4.335 (-2.68%)

PFE Pfizer
$37.35 /

+0.37 (+1.00%)

MRNA Moderna
$147.74 /

+8.45 (+6.07%)

JNJ Johnson & Johnson
$157.25 /

-4.335 (-2.68%)

Recommendations
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers » 09:33
04/13/21
04/13
09:33
04/13/21
09:33
JNJ

Johnson & Johnson

$161.62 /

+0.42 (+0.26%)

, MRNA

Moderna

$139.36 /

-1.52 (-1.08%)

, PFE

Pfizer

$36.98 /

+0.38 (+1.04%)

After the FDA and CDC put…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$36.98 /

+0.38 (+1.04%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

09:21 Today JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
08:15 Today Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
MRNA Moderna
$139.36 /

-1.52 (-1.08%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
03/01/21 Chardan
Moderna price target raised to $182 from $107 at Chardan
PFE Pfizer
$36.98 /

+0.38 (+1.04%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
PFE Pfizer
$36.98 /

+0.38 (+1.04%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

  • 19
    May
PFE Pfizer
$36.98 /

+0.38 (+1.04%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

PFE Pfizer
$36.98 /

+0.38 (+1.04%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

PFE Pfizer
$36.98 /

+0.38 (+1.04%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

Hot Stocks
Moderna says available mRNA-1273 data doesn't suggest association with CVST » 09:28
04/13/21
04/13
09:28
04/13/21
09:28
MRNA

Moderna

$139.36 /

-1.52 (-1.08%)

After the CDC and FDA…

After the CDC and FDA recommended a pause in the use of Johnson & Johnson's (JNJ) COVID-19 vaccine, Moderna (MRNA) issued the following statement: "A comprehensive assessment of the totality of the available safety data for mRNA-1273 after over 64.5 million doses administered globally does not suggest an association with cerebral venous sinus thrombosis - CVST - or thrombotic events. Analyses performed using data through March 22, 2021. Number of vaccinations was derived from the U.S. Centers for Disease Control and Prevention website, European Centre for Disease Prevention and Control website, and inferred for other countries based on distribution and the proportion of doses distributed administered in EX-U.S. settings." Reference Link

ShowHide Related Items >><<
MRNA Moderna
$139.36 /

-1.52 (-1.08%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

08:15 Today Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
03/01/21 Chardan
Moderna price target raised to $182 from $107 at Chardan
MRNA Moderna
$139.36 /

-1.52 (-1.08%)

  • 19
    May
MRNA Moderna
$139.36 /

-1.52 (-1.08%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

On The Fly
Fly Intel: Pre-market Movers » 08:58
04/13/21
04/13
08:58
04/13/21
08:58
AGC

Altimeter Growth

$13.94 /

+0.21 (+1.53%)

, NVCR

Novocure

$131.91 /

-0.1 (-0.08%)

, CDLX

Cardlytics

$111.96 /

+0.81 (+0.73%)

, MRNA

Moderna

$139.36 /

-1.52 (-1.08%)

, MFNC

Mackinac Financial

$13.26 /

-0.23 (-1.70%)

, FAST

Fastenal

$50.73 /

+0.7 (+1.40%)

, ATXI

Avenue Therapeutics

$7.11 /

+0.215 (+3.12%)

, BALY

Bally's

$60.79 /

-0.885 (-1.43%)

, AAL

American Airlines

$22.92 /

-0.625 (-2.66%)

, JNJ

Johnson & Johnson

$161.62 /

+0.42 (+0.26%)

Check out this morning's…

ShowHide Related Items >><<
NVCR Novocure
$131.91 /

-0.1 (-0.08%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

MFNC Mackinac Financial
$13.26 /

-0.23 (-1.70%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

FAST Fastenal
$50.73 /

+0.7 (+1.40%)

CDLX Cardlytics
$111.96 /

+0.81 (+0.73%)

BALY Bally's
$60.79 /

-0.885 (-1.43%)

ATXI Avenue Therapeutics
$7.11 /

+0.215 (+3.12%)

AGC Altimeter Growth
$13.94 /

+0.21 (+1.53%)

AAL American Airlines
$22.92 /

-0.625 (-2.66%)

AGC Altimeter Growth
$13.94 /

+0.21 (+1.53%)

NVCR Novocure
$131.91 /

-0.1 (-0.08%)

03/01/21 Mizuho
Novocure price target raised to $175 from $150 at Mizuho
02/25/21 Piper Sandler
'Overreaction to downside' in Novocure a buying opportunity, says Piper Sandler
01/29/21 Truist
Novocure price target raised to $132 from $118 at Truist
01/25/21 Piper Sandler
Novocure price target raised to $225 from $140 at Piper Sandler
CDLX Cardlytics
$111.96 /

+0.81 (+0.73%)

03/16/21 JPMorgan
Cardlytics price target raised to $130 from $110 at JPMorgan
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/02/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
MRNA Moderna
$139.36 /

-1.52 (-1.08%)

08:15 Today Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
03/01/21 Chardan
Moderna price target raised to $182 from $107 at Chardan
MFNC Mackinac Financial
$13.26 /

-0.23 (-1.70%)

FAST Fastenal
$50.73 /

+0.7 (+1.40%)

01/21/21 Baird
Fastenal should be bought on any weakness, says Baird
12/31/20 William Blair
Azek, Trex among Blair's top Specialty Distribution ideas for 2021
12/16/20 Deutsche Bank
Fastenal downgraded to Hold from Buy at Deutsche Bank
10/15/20 Stephens
Fastenal resumed with an Overweight at Stephens
ATXI Avenue Therapeutics
$7.11 /

+0.215 (+3.12%)

03/01/21 H.C. Wainwright
InvaGen takeout 'may still be in play' at Avenue, says H.C. Wainwright
02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
10/12/20 H.C. Wainwright
Avenue downgraded to Neutral on merger uncertainty at H.C. Wainwright
10/12/20 H.C. Wainwright
Avenue Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
BALY Bally's
$60.79 /

-0.885 (-1.43%)

04/08/21 KeyBanc
Bally's price target raised to $70 from $65 at KeyBanc
03/29/21 Truist
Early March casino data looks 'very positive,' says Truist
03/25/21 Stifel
Bally's price target raised to $75 from $70 at Stifel
03/24/21 Jefferies
Gamesys Group and Bally's an 'interesting combination,' says Jefferies
AAL American Airlines
$22.92 /

-0.625 (-2.66%)

04/06/21 Morgan Stanley
American Airlines initiated with an Underweight at Morgan Stanley
03/30/21
Fly Intel: Top five analyst upgrades
03/30/21 Jefferies
Jefferies upgrades American Airlines to Hold on outperformance potential
03/30/21 Citi
Citi takes 'cautious view' on American Airlines capacity additions
JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
NVCR Novocure
$131.91 /

-0.1 (-0.08%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

FAST Fastenal
$50.73 /

+0.7 (+1.40%)

CDLX Cardlytics
$111.96 /

+0.81 (+0.73%)

BALY Bally's
$60.79 /

-0.885 (-1.43%)

AAL American Airlines
$22.92 /

-0.625 (-2.66%)

  • 16
    Apr
  • 03
    Mar
  • 10
    Nov
  • 23
    Jun
  • 19
    May
MRNA Moderna
$139.36 /

-1.52 (-1.08%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

BALY Bally's
$60.79 /

-0.885 (-1.43%)

AGC Altimeter Growth
$13.94 /

+0.21 (+1.53%)

AAL American Airlines
$22.92 /

-0.625 (-2.66%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

MFNC Mackinac Financial
$13.26 /

-0.23 (-1.70%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

FAST Fastenal
$50.73 /

+0.7 (+1.40%)

BALY Bally's
$60.79 /

-0.885 (-1.43%)

AGC Altimeter Growth
$13.94 /

+0.21 (+1.53%)

AAL American Airlines
$22.92 /

-0.625 (-2.66%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

AGC Altimeter Growth
$13.94 /

+0.21 (+1.53%)

AAL American Airlines
$22.92 /

-0.625 (-2.66%)

Recommendations
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause » 08:15
04/13/21
04/13
08:15
04/13/21
08:15
MRNA

Moderna

/

+

, JNJ

Johnson & Johnson

$161.62 /

+0.42 (+0.26%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
/

+

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

MRNA Moderna
/

+

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
03/01/21 Chardan
Moderna price target raised to $182 from $107 at Chardan
02/26/21 Barclays
Moderna price target raised to $178 from $169 at Barclays
JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
MRNA Moderna
/

+

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

  • 19
    May
MRNA Moderna
/

+

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

MRNA Moderna
/

+

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

MRNA Moderna
/

+

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

Hot Stocks
Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use » 07:53
04/13/21
04/13
07:53
04/13/21
07:53
MRNA

Moderna

$139.36 /

-1.52 (-1.08%)

, PFE

Pfizer

$36.98 /

+0.38 (+1.04%)

, JNJ

Johnson & Johnson

$161.62 /

+0.42 (+0.26%)

Pfizer (PFE) shares are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$36.98 /

+0.38 (+1.04%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
03/01/21 Chardan
Moderna price target raised to $182 from $107 at Chardan
02/26/21 Barclays
Moderna price target raised to $178 from $169 at Barclays
PFE Pfizer
$36.98 /

+0.38 (+1.04%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
PFE Pfizer
$36.98 /

+0.38 (+1.04%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

  • 19
    May
PFE Pfizer
$36.98 /

+0.38 (+1.04%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

PFE Pfizer
$36.98 /

+0.38 (+1.04%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

PFE Pfizer
$36.98 /

+0.38 (+1.04%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

Yesterday
Initiation
Fly Intel: Top five analyst initiations » 09:54
04/12/21
04/12
09:54
04/12/21
09:54
OLO

Olo

$27.50 /

-0.78 (-2.76%)

, NAPA

Duckhorn Portfolio

$18.20 /

-0.685 (-3.63%)

, TSM

TSMC

$120.85 /

-1.92 (-1.56%)

, AMT

American Tower

$240.05 /

+0.995 (+0.42%)

, TWST

Twist Bioscience

$131.90 /

-1.21 (-0.91%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Olo (OLO) initiated with a Buy at Truist, an Overweight at Piper Sandler and JPMorgan, an Outperform at RBC Capital, and William Blair and initiated with a Neutral at Goldman Sachs. 2. Duckhorn Portfolio (NAPA) initiated with an Outperform at Credit Suisse and Evercore ISI, initiated with an Overweight at JPMorgan, initiated with a Buy at BofA, Jefferies and Citi, initiated with a Sector Perform at RBC Capital and initiated with an Equal Weight at Barclays. 3. TSMC (TSM) initiated with a Neutral at Atlantic Equities. 4. American Tower (AMT) initiated with a Buy at Jefferies. 5. Twist Bioscience (TWST) initiated with an Overweight at Piper Sandler. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, Reference Link

ShowHide Related Items >><<
TWST Twist Bioscience
$131.90 /

-1.21 (-0.91%)

TSM TSMC
$120.85 /

-1.92 (-1.56%)

OLO Olo
$27.50 /

-0.78 (-2.76%)

AMT American Tower
$240.05 /

+0.995 (+0.42%)

OLO Olo
$27.50 /

-0.78 (-2.76%)

04/12/21 William Blair
Olo initiated with an Outperform at William Blair
04/12/21 Truist
Truist starts Olo with a Buy, sees sustained 30% or more growth potential
04/12/21 JPMorgan
Olo initiated with an Overweight at JPMorgan
04/12/21 Truist
Olo initiated with a Buy at Truist
NAPA Duckhorn Portfolio
$18.20 /

-0.685 (-3.63%)

04/12/21 Evercore ISI
Evercore ISI starts 'blue chip' Duckhorn at Outperform with $22 price target
04/12/21 Jefferies
Duckhorn Portfolio initiated with a Buy at Jefferies
04/12/21 JPMorgan
Duckhorn Portfolio initiated with an Overweight at JPMorgan
04/12/21 Citi
Duckhorn Portfolio initiated with a Buy at Citi
TSM TSMC
$120.85 /

-1.92 (-1.56%)

04/12/21 Atlantic Equities
TSMC initiated with a Neutral at Atlantic Equities
04/01/21 DA Davidson
Onto Innovation price target raised to $80 from $75 at DA Davidson
03/29/21 Citi
TSMC recent selloff brings 'enhanced buying opportunity,' says Citi
03/25/21 Northland
Northland upgrades AMD to Outperform on Intel's 'strategic faux pas'
AMT American Tower
$240.05 /

+0.995 (+0.42%)

04/12/21 Jefferies
American Tower initiated with a Buy at Jefferies
03/25/21 KeyBanc
American Tower upgraded to Overweight from Sector Weight at KeyBanc
03/18/21 Wolfe Research
American Tower initiated with an Outperform at Wolfe Research
03/08/21 RBC Capital
American Tower price target lowered to $250 from $275 at RBC Capital
TWST Twist Bioscience
$131.90 /

-1.21 (-0.91%)

04/12/21 Piper Sandler
Twist Bioscience initiated with an Overweight at Piper Sandler
02/05/21 Baird
Twist Bioscience price target raised to $200 from $125 at Baird
02/05/21 JPMorgan
Twist Bioscience downgraded to Underweight from Neutral at JPMorgan
01/04/21 Evercore ISI
Evercore ISI cuts Twist Bioscience to In Line, says new verticals take time
TWST Twist Bioscience
$131.90 /

-1.21 (-0.91%)

TSM TSMC
$120.85 /

-1.92 (-1.56%)

AMT American Tower
$240.05 /

+0.995 (+0.42%)

  • 18
    Mar
  • 17
    Mar
  • 03
    Dec
  • 04
    Jun
TSM TSMC
$120.85 /

-1.92 (-1.56%)

OLO Olo
$27.50 /

-0.78 (-2.76%)

TWST Twist Bioscience
$131.90 /

-1.21 (-0.91%)

TSM TSMC
$120.85 /

-1.92 (-1.56%)

OLO Olo
$27.50 /

-0.78 (-2.76%)

TSM TSMC
$120.85 /

-1.92 (-1.56%)

OLO Olo
$27.50 /

-0.78 (-2.76%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.